Status:
RECRUITING
A 3-day Course for CFS/ME
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
University of Oslo
Haukeland University Hospital
Conditions:
Chronic Fatigue Syndrome
Myalgic Encephalomyelitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) can be a serious and disabling condition with a heavy symptom burden and low function. Work disability is common, and social life dramatical...
Detailed Description
This is a randomized controlled trial (RCT) to investigate potential effects (positive and negative) of a 3-day course with follow-up for 100 adults with CFS/ME. The 3-day course used in this trial i...
Eligibility Criteria
Inclusion
- CFS/ME diagnosis based on the Canada Consensus Criteria.
- At least 50% out of school/work.
- Readiness to change (corresponding to the preparation phase in transtheoretical model)
- Has given informed consent.
Exclusion
- Assessed by a General Practitioner (GP):
- Underlying physical illness or mental disorder that may explain the symptoms.
- Suicide risk/previous suicide attempts.
- Pregnancy.
- Bedridden and in need of continuous care.
- Insufficient Norwegian speaking or writing skills to participate in the 3-day course and fill out questionnaires.
Key Trial Info
Start Date :
March 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05236465
Start Date
March 21 2022
End Date
December 1 2028
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychology, NTNU
Trondheim, Norway